Business Leaders

Victor Sandor

Alter : 55

Vermögen : 57 247 USD

Größte Unternehmen :

Kymera Therapeutics, Inc. -

Merus N.V. -

ADC Therapeutics SA -

Prelude Therapeutics Incorporated

Übersicht

Victor Sandor is on the board of Merus NV and 4 other companies.

Dr. Sandor previously occupied the position of SVP-Global Clinical Development at Incyte Corp., Chief Medical Officer of Array BioPharma, Inc. and Chief Medical Officer-Oncology division & VP at Biogen Idec, Inc. (North Carolina).

He received a doctorate from McGill University.

Aktuelle Stellungen und Verantwortungsbereiche Victor Sandor

Name	Titel	Seit
Kymera Therapeutics, Inc. (Biotechnologie)	Independent Director	2022
Merus N.V. (Biotechnologie)	Independent Non-Executive Director	2019
ADC Therapeutics SA (Biotechnologie)	Independent Non-Executive Director	2020
Prelude Therapeutics Incorporated (Biotechnologie)	Independent Director	-
Istari Oncology, Inc.	Director	-

Anteile an Victor Sandor

Name	Aktien	%	Bewertung
ADC Therapeutics SA (ADCT) (Biotechnologie)	14 908	0,019%	57 247 USD
Merus N.V. (MRUS) (Biotechnologie)	0	0,0000%	0 USD
Prelude Therapeutics Incorporated (PRLD) (Biotechnologie)	0	0,0000%	0 USD
Kymera Therapeutics, Inc. (KYMR) (Biotechnologie)	0	0,0000%	0 USD

Victor Sandor: Persönliches Netzwerk

Name	Verbundene Unternehmen
Viviane Monges	ADC Therapeutics SA
Kimberly Pope	ADC Therapeutics SA
Jane Huang	Prelude Therapeutics Incorporated
Thomas Pfisterer	ADC Therapeutics SA
Anne Noordzij	Merus N.V.
Tyrell J. Rivers	ADC Therapeutics SA
Gorjan Hrustanovic	Kymera Therapeutics, Inc.
Vijay Sabesan	Kymera Therapeutics, Inc.
Len Kanavy	Merus N.V.
Krishna Vaddi	Prelude Therapeutics Incorporated